• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Spectrum Disease.

作者信息

Eliades Philip, Fonseca Maíra, Harp Joanna

机构信息

Department of Dermatology, NewYork-Presbyterian/Weill Cornell Medical Center, New York, New York.

Lincoln Medical Center, New York, New York.

出版信息

JAMA Dermatol. 2020 Aug 1;156(8):921-922. doi: 10.1001/jamadermatol.2019.3731.

DOI:10.1001/jamadermatol.2019.3731
PMID:32347889
Abstract
摘要

相似文献

1
Use of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Spectrum Disease.依那西普在一系列史蒂文斯-约翰逊综合征-中毒性表皮坏死松解症谱系疾病儿科患者中的应用。
JAMA Dermatol. 2020 Aug 1;156(8):921-922. doi: 10.1001/jamadermatol.2019.3731.
2
A new case series on etanercept treatment for toxic epidermal necrolysis.关于依那西普治疗中毒性表皮坏死松解症的新病例系列。
Eur J Dermatol. 2020 Oct 1;30(5):561-568. doi: 10.1684/ejd.2020.3883.
3
Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.依那西普治疗儿童史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症。
J Cutan Med Surg. 2018 Sep/Oct;22(5):514-515. doi: 10.1177/1203475418758989. Epub 2018 Feb 9.
4
The use of etanercept for treatment of toxic epidermal necrolysis when toxic shock syndrome is in the differential.在鉴别中毒性休克综合征时，使用依那西普治疗中毒性表皮坏死松解症。
Dermatol Ther. 2018 Sep;31(5):e12684. doi: 10.1111/dth.12684. Epub 2018 Sep 2.
5
Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution.对一家儿科三级医疗机构中药物性史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症病例的回顾性研究。
Pediatr Dermatol. 2020 May;37(3):461-466. doi: 10.1111/pde.14118. Epub 2020 Feb 14.
6
Etanercept therapy for toxic epidermal necrolysis.依那西普治疗中毒性表皮坏死松解症。
J Am Acad Dermatol. 2014 Aug;71(2):278-83. doi: 10.1016/j.jaad.2014.04.044. Epub 2014 Jun 11.
7
Post hoc Analysis of Role of Etanercept in Ocular Sequelae of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.依那西普在史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症眼部后遗症中作用的事后分析
Ophthalmology. 2024 Jul;131(7):864-866. doi: 10.1016/j.ophtha.2024.03.023. Epub 2024 Mar 30.
8
Pediatric SJS/TEN Subdued by a Combination of Dexamethasone, Cyclosporine, and Etanercept.儿科 SJS/TEN 经地塞米松、环孢素和依那西普联合治疗得到控制。
J Cutan Med Surg. 2019 Sep/Oct;23(5):547-550. doi: 10.1177/1203475419861078.
9
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Treatment With a Biologic: A Case Report.史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症及生物制剂治疗：一例报告
Perm J. 2017;21:16-060. doi: 10.7812/TPP/16-060.
10
Successful treatment of interstitial lung disease related to Stevens-Johnson syndrome/toxic epidermal necrolysis overlap with etanercept: A case report and published work review.成功治疗依那西普相关史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症重叠性间质性肺病：病例报告及文献复习。
J Dermatol. 2019 Nov;46(11):1035-1038. doi: 10.1111/1346-8138.15058. Epub 2019 Aug 22.

引用本文的文献

1
Challenges in Diagnosing and Treatment of Pediatric Necrotic Skin Conditions: A Retrospective Study.小儿坏死性皮肤疾病的诊断与治疗挑战：一项回顾性研究
Med Sci Monit. 2025 Aug 16;31:e948373. doi: 10.12659/MSM.948373.
2
Case Report: Multi-targeted therapy in the treatment of severe toxic epidermal necrolysis.病例报告：多靶点疗法治疗重症中毒性表皮坏死松解症
Front Pediatr. 2024 Nov 22;12:1460579. doi: 10.3389/fped.2024.1460579. eCollection 2024.
3
Etanercept treatment for pediatric toxic epidermal necrolysis induced by deflazacort: a case report and literature review.
依那西普治疗地夫可特诱导儿童中毒性表皮坏死松解症 1 例报告并文献复习
Front Immunol. 2024 Jan 25;15:1342898. doi: 10.3389/fimmu.2024.1342898. eCollection 2024.
4
Biologic TNF-α Inhibitors for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis.用于史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症及中毒性表皮坏死松解症-史蒂文斯-约翰逊综合征重叠综合征的生物肿瘤坏死因子-α抑制剂：一项研究水平和患者水平的荟萃分析
Dermatol Ther (Heidelb). 2023 Jun;13(6):1305-1327. doi: 10.1007/s13555-023-00928-w. Epub 2023 May 13.
5
Reactive infectious mucocutaneous eruption - repeat etanercept after intravenous immunoglobulin: A case report.反应性感染性黏膜皮肤疹——静脉注射免疫球蛋白后重复使用依那西普：病例报告
SAGE Open Med Case Rep. 2022 Aug 17;10:2050313X221117887. doi: 10.1177/2050313X221117887. eCollection 2022.
6
Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.儿童患者药物诱导性表皮坏死松解症（DEN）的管理：从药物诱导性史蒂文斯-约翰逊综合征、重叠和中毒性表皮坏死松解症到 DEN 的单一统一诊断。
Paediatr Drugs. 2022 Jul;24(4):307-319. doi: 10.1007/s40272-022-00515-0. Epub 2022 Jun 9.
7
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.全身性治疗史蒂文斯-约翰逊综合征（SJS）、中毒性表皮坏死松解症（TEN）和 SJS/TEN 重叠综合征。
Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.